Past Boards of Directors
Scientific background: Maria Serrano read her Cellular and Molecular Pathology BSc at Bristol University. She then carried on at the same institution for her PhD in Immunology, working on the Immunology of non-conventional Intraepithelial Lymphocytes. After a few years in publishing, she returned to research at the Bristol Heart Institute investigating the use of Mesenchymal Stem Cells for heart repair in humans. She later took an appointment at Guy’s Hospital London working with Adrian Hayday on the use of GammaDelta T cells for the treatment of Prostate Cancer. Currently, she works at University College London as a Clinical Trial Coordinator and Research Associate for first-in-human Phase I trials using Genetically Modified T cells as Cellular therapy for the treatment of Haematological malignancies.
Opinion about SRUK: I have always been interested in creating communication bridges between departments/institutions and countries as I believe this provides an exponential improvement to scientific (or any intellectual) advancement as well as a great pleasure and interdisciplinary enlightment. Hence, SRUK/CERU ticked those boxes to perfection as a target and project.